Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Southern District of New York, Case No. 1:20-cv-01576-LJL, which on March 5, 2020 was consolidated into No. 1:20-cv-01010-LJL, on behalf of shareholders of Telaria, Inc. (“Telaria” or the “Company”) (NYSE:TLRA) who have been harmed by Telaria’s and its board of directors’ (the “Board”) alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) in connection with the proposed merger of the Company with The Rubicon Project, Inc. (the “Proposed Transaction”).
On December 19, 2019, the Board caused the Company to enter into an agreement and plan of merger under which Telaria shareholders stand to receive 1.082 shares of The Rubicon Project, Inc. for each share of Telaria stock they own.
The complaint alleges that the Registration Statement filed with the Securities and Exchange Commission violates Sections 14(a) and 20(a) of the Exchange Act because it provides materially incomplete and misleading information about the Company and the Proposed Transaction, including information concerning the Company’s financial projections and analysis, on which the Board relied to recommend the Proposed Transaction as fair to Telaria shareholders.
If you wish to serve as lead plaintiff, you must move the Court no later than May 4, 2020 from the date of this notice. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you wish to obtain information concerning this action, you can do so completing the form below.
Telaria, Inc. (TLRA)
* The submission of this form does not create an attorney-client relationship.
Filed on 03/10/2020
Court Southern District of New York
Lead Plaintiff Deadline 05/04/2020
685 Third Avenue 26th Floor
10017 New York, New York
Phone (212) 983-9330
Fax (212) 983-9331
James M. Wilson, Jr. firstname.lastname@example.org Phone (212) 983-9330 Fax (212) 983-9331